89Bio (ETNB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Oct31

Seedhouse Analyst Covers Healthcare Sector, Focusing on Multiple Stocks

15:02

Oct30

Roche Completes Acquisition of Approximately 60.49% Shares of 89bio

06:01

Oct27

Roche Reports Quarterly Revenue Drop and Acquires 89bio to Strengthen Position in Metabolic Diseases

19:51

Oct23

Roche Plans to Acquire 89bio for up to $3.5 Billion

05:00

Sep30

89bio shareholders to gain up to $3.5 billion through Roche acquisition deal

16:52

Sep23

Roche Acquires 89bio for $2.4 Billion to Obtain Potential MASH Blockbuster Drug

02:07

Schedules & Filings

Schedules

Filings

Aug8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -111.5 M, EPS -0.7062

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -71.28 M, EPS -0.4869

Feb27

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -118.35 M, EPS -1.0206

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change